Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;71(3):422-428.
doi: 10.1161/HYPERTENSIONAHA.117.10546. Epub 2018 Jan 15.

Hypertension and Diabetes Mellitus: Coprediction and Time Trajectories

Affiliations

Hypertension and Diabetes Mellitus: Coprediction and Time Trajectories

Vasilis Tsimihodimos et al. Hypertension. 2018 Mar.

Abstract

Type 2 diabetes mellitus and hypertension overlap in the population. In many subjects, development of diabetes mellitus is characterized by a relatively rapid increase in plasma glucose values. Whether a similar phenomenon occurs during the development of hypertension is not known. We analyzed the pattern of blood pressure (BP) changes during the development of hypertension in patients with or without diabetes mellitus using data from the MCDS (Mexico City Diabetes Study; a population-based study of diabetes mellitus in Hispanic whites) and in the FOS (Framingham Offspring Study, a community-based study in non-Hispanic whites) during a 7-year follow-up. Diabetes mellitus at baseline was a significant predictor of incident hypertension (in FOS, odds ratio, 3.14; 95% confidence interval, 2.17-4.54) independently of sex, age, body mass index, and familial diabetes mellitus. Conversely, hypertension at baseline was an independent predictor of incident diabetes mellitus (in FOS, odds ratio, 3.33; 95% CI, 2.50-4.44). In >60% of the converters, progression from normotension to hypertension was characterized by a steep increase in BP values, averaging 20 mm Hg for systolic BP within 3.5 years (in MCDS). In comparison with the nonconverters group, hypertension and diabetes mellitus converters shared a metabolic syndrome phenotype (hyperinsulinemia, higher body mass index, waist girth, BP, heart rate and pulse pressure, and dyslipidemia). Overall, results were similar in the 2 ethnic groups. We conclude that (1) development of hypertension and diabetes mellitus track each other over time, (2) transition from normotension to hypertension is characterized by a sharp increase in BP values, and (3) insulin resistance is one common feature of both prediabetes and prehypertension and an antecedent of progression to 2 respective disease states.

Keywords: blood pressure; diabetes mellitus; heart rate; hypertension; insulin resistance.

PubMed Disclaimer

Conflict of interest statement

Disclosures

None of the authors has any conflict of interest to report.

Figures

Figure 1
Figure 1
Multivariate logistic analysis of incident hypertension in normotensive individuals in the Mexico City Diabetes Study (MCDS) and Framingham Offspring Study (FOS). Plots are odds ratios and 95% confidence intervals (calculated for 1 SD of continuous predictor variable).
Figure 2
Figure 2
Systolic and diastolic blood pressure values in normotensive subjects who remained normotensive at both follow-up examinations (blue lines), became hypertensive at the first examination (green lines) or at the second examination (red lines). Plots are mean±SD. The dotted green lines indicate that the apparent decline in BP values after diagnosis are likely due to anthypertensive treatment.
Figure 3
Figure 3
Multivariate logistic analysis of incident diabetes in nondiabetic individuals in the Mexico City Diabetes Study (MCDS) and Framingham Offspring Study (FOS). Plots are odds ratios and 95% confidence intervals (calculated for 1 SD of continuous predictor variable; data are adjusted for smoking categorized as ever or not).
Figure 4
Figure 4
Multivariate logistic analysis of incident hypertension or diabetes in the Mexico City Diabetes Study. Plots are odds ratios and 95% confidence intervals (calculated for 1 SD of continuous predictor variable).

References

    1. Ferrannini E, Cushman WC. Diabetes and hypertension: The bad companions. Lancet. 2012;380:601–610. - PubMed
    1. Perreault L, Pan Q, Aroda VR, Barrett-Connor E, Dabelea D, Dagogo-Jack S, Hamman RF, Kahn SE, Mather KJ, Knowler WC Diabetes Prevention Program Research Group. Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS) Diabet Med. 2017;34:1747–1755. - PMC - PubMed
    1. Wei GS, Coady SA, Goff DC, Jr, Brancati FL, Levy D, Selvin E, Vasan RS, Fox CS. Blood pressure and the risk of developing diabetes in african americans and whites: ARIC, CARDIA, and the Framingham Heart Study. Diabetes Care. 2011;34:873–879. - PMC - PubMed
    1. Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, Molitch ME, Pi-Sunyer X, Darwin C, Heckman-Stoddard BM, Temprosa M, Kahn SE, Nathan DM Diabetes Prevention Program Research Group. Metformin for diabetes prevention: Insights gained from the diabetes prevention program/diabetes prevention program outcomes study. Diabetologia. 2017;60:1601–1611. - PMC - PubMed
    1. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT study group. Lancet. 1998;351:1755–1762. - PubMed

Publication types

MeSH terms